Vascular Parkinsonism
12
3
4
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.3%
1 terminated out of 12 trials
85.7%
-0.8% vs benchmark
8%
1 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 6 completed trials
Clinical Trials (12)
Exploration of the Association Between White Matter Lesion Burden and Dalfampridine Response in Insidious-Onset Vascular Parkinsonism
Trial of Parkinson's And Zoledronic Acid
Etiology-Phenotype-Outcome Pathway Study on Freezing of Gait (FOG)
Community Outreach for Palliative Engagement -- Parkinson Disease
AI-Enhanced Optimization of Acute Levodopa Challenge Test
The Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related Disorders
Differences Between Patients With Vascular Parkinsonism and Parkinson's Disease
Complex Eye Movements in Parkinson's Disease and Related Movement Disorders
rTMS Treatment in Vascular Parkinsonism
Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes
18F-DTBZ PET and Multi-modal MRI in the Patients With Vascular Parkinsonism
Magnetic Resonance Imaging in the Diagnosis of Parkinsonian Syndromes